Caladrius Biosciences

Douglas Losordo, M.D., Chief Medical Officer, EVP, Global Head of Research and Development
Basking Ridge, NJ
(NASDAQ: CLBS)
Caladrius Biosciences is a clinical-stage biopharmaceutical company dedicated to the development of cellular therapies designed to reverse, not manage, disease. We are developing a first-in-class cell therapy product that is based on the notion that our body contains finely tuned mechanisms for self-repair. Our technology leverages and enables these mechanisms in the form of specific cells, using formulations and modes of delivery unique to each medical indication.
www.caladrius.com



By using this website you agree to accept our Privacy Policy and Terms & Conditions